Surrogate endpoints: wishful thinking or reality?
作者： Tomasz Burzykowski
关键词: Wishful thinking 、 Surrogate endpoint 、 Psychotherapist 、 Medicine
摘要:
sagepub.com
sci-hub.se 参考文章(13)
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework* Clinical Pharmacology & Therapeutics. ,vol. 69, pp. 89- 95 ,(2001) , 10.1067/MCP.2001.113989
Stuart G Baker, Barnett S Kramer, A perfect correlate does not a surrogate make. BMC Medical Research Methodology. ,vol. 3, pp. 16- 16 ,(2003) , 10.1186/1471-2288-3-16
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. Journal of Clinical Oncology. ,vol. 22, pp. 3766- 3775 ,(2004) , 10.1200/JCO.2004.03.104
Marc Buyse, Geert Molenberghs, Criteria for the validation of surrogate endpoints in randomized experiments Biometrics. ,vol. 54, pp. 1014- 1029 ,(1998) , 10.2307/2533853
Michael J. Daniels, Michael D. Hughes, Meta-analysis for the evaluation of potential surrogate markers Statistics in Medicine. ,vol. 16, pp. 1965- 1982 ,(1997) , 10.1002/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.0.CO;2-M
D. Cunningham, J. Zalcberg, J. Maroun, R. James, S. Clarke, T.S. Maughan, M. Vincent, J. Schulz, M. González Barón, T. Facchini, Efficacy, tolerability and management of raltitrexed (Tomudex) monotherapy in patients with advanced colorectal cancer. a review of phase II/III trials. European Journal of Cancer. ,vol. 38, pp. 478- 486 ,(2002) , 10.1016/S0959-8049(01)00413-0
Mitchell H Gail, Ruth Pfeiffer, Hans C Van Houwelingen, Raymond J Carroll, On meta-analytic assessment of surrogate outcomes Biostatistics. ,vol. 1, pp. 231- 246 ,(2000) , 10.1093/BIOSTATISTICS/1.3.231
Stuart G. Baker, A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint. Biostatistics. ,vol. 7, pp. 58- 70 ,(2006) , 10.1093/BIOSTATISTICS/KXI040
M. Buyse, G. Molenberghs, T. Burzykowski, D. Renard, H. Geys, The validation of surrogate endpoints in meta-analyses of
randomized experiments Biostatistics. ,vol. 1, pp. 49- 67 ,(2000) , 10.1093/BIOSTATISTICS/1.1.49
Laurence S. Freedman, Barry I. Graubard, Arthur Schatzkin, Statistical validation of intermediate endpoints for chronic diseases. Statistics in Medicine. ,vol. 11, pp. 167- 178 ,(1992) , 10.1002/SIM.4780110204